Cargando…

Concurrent targeting of MAP3K3 and BRD4 by miR-3140-3p overcomes acquired resistance to BET inhibitors in neuroblastoma cells

Neuroblastoma (NB) harboring MYCN amplification is a refractory disease with a poor prognosis. As BRD4, an epigenetic reader belonging to the bromodomain and extra terminal domain (BET) family, drives transcription of MYCN in NB cells, BET inhibitors (BETis) are considered useful for NB therapy. How...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Chang, Gen, Yasuyuki, Tanimoto, Kousuke, Muramatsu, Tomoki, Inoue, Jun, Inazawa, Johji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253920/ https://www.ncbi.nlm.nih.gov/pubmed/34258104 http://dx.doi.org/10.1016/j.omtn.2021.05.001

Ejemplares similares

miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein
por: Tonouchi, Erina, et al.
Publicado: (2018)

Publisher Correction: miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein
por: Tonouchi, Erina, et al.
Publicado: (2018)

Massive computational identification of somatic variants in exonic splicing enhancers using The Cancer Genome Atlas
por: Tanimoto, Kousuke, et al.
Publicado: (2019)

miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer
por: Hiramoto, Hidekazu, et al.
Publicado: (2017)

BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis
por: Roberts, Thomas C., et al.
Publicado: (2017)

BET Bromodomain Proteins Brd2, Brd3 and Brd4 Selectively Regulate Metabolic Pathways in the Pancreatic β-Cell
por: Deeney, Jude T., et al.
Publicado: (2016)

The BRD4 Inhibitor dBET57 Exerts Anticancer Effects by Targeting Superenhancer-Related Genes in Neuroblastoma
por: Jia, Si-Qi, et al.
Publicado: (2022)

Integrative genome‐wide analyses reveal the transcriptional aberrations in Japanese esophageal squamous cell carcinoma
por: Takemoto, Akira, et al.
Publicado: (2021)

Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma
por: Sakha, Sujata, et al.
Publicado: (2016)

Identification and characterization of transforming growth factor beta‐induced in circulating tumor cell subline from pancreatic cancer cell line
por: Sato, Taku, et al.
Publicado: (2018)

Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma
por: Nagata, Hiroaki, et al.
Publicado: (2017)

Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function
por: Cribbs, Adam P., et al.
Publicado: (2021)

BRD4: A BET(ter) target for the treatment of AML?
por: Valent, Peter, et al.
Publicado: (2014)

PIK3CA c.3140A>G mutation in a patient with suspected Proteus Syndrome: a case report
por: Valentini, Virginia, et al.
Publicado: (2018)

C04-C08 Gap divider (PS/RF-HC 3140)
por: Paoluzzi, M
Publicado: (1996)

C04-C08 gap divider (PS/RF-HC 3140)
por: Paoluzzi, M
Publicado: (1996)

BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice
por: Korb, Erica, et al.
Publicado: (2015)

BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells
por: Coudé, Marie-Magdelaine, et al.
Publicado: (2015)

BRD9 regulates interferon-stimulated genes during macrophage activation via cooperation with BET protein BRD4
por: Ahmed, Nasiha S., et al.
Publicado: (2021)

Lysosomal-Associated Protein Multispanning Transmembrane 5 Gene (LAPTM5) Is Associated with Spontaneous Regression of Neuroblastomas
por: Inoue, Jun, et al.
Publicado: (2009)

Preparation data of the bromodomains BRD3(1), BRD3(2), BRD4(1), and BRPF1B and crystallization of BRD4(1)-inhibitor complexes
por: Hügle, Martin, et al.
Publicado: (2016)

Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
por: Zengerle, Michael, et al.
Publicado: (2015)

BETting on combination to overcome PARPi resistance
por: Zhang, Youyou, et al.
Publicado: (2017)

Enhanced JunD/RSK3 signalling due to loss of BRD4/FOXD3/miR-548d-3p axis determines BET inhibition resistance
por: Tai, Fang, et al.
Publicado: (2020)

The Tumor-Suppressive miR-497-195 Cluster Targets Multiple Cell-Cycle Regulators in Hepatocellular Carcinoma
por: Furuta, Mayuko, et al.
Publicado: (2013)

Receptor tyrosine kinase amplification is predictive of distant metastasis in patients with oral squamous cell carcinoma
por: Oikawa, Yu, et al.
Publicado: (2017)

The BET/BRD inhibitor JQ1 improves brain plasticity in WT and APP mice
por: Benito, E, et al.
Publicado: (2017)

Resistance to BET inhibitors in lung adenocarcinoma is mediated by casein kinase phosphorylation of BRD4
por: Calder, Jack, et al.
Publicado: (2021)

Phosphorylation-dependent BRD4 dimerization and implications for therapeutic inhibition of BET family proteins
por: Malvezzi, Francesca, et al.
Publicado: (2021)

miR-655 Is an EMT-Suppressive MicroRNA Targeting ZEB1 and TGFBR2
por: Harazono, Yosuke, et al.
Publicado: (2013)

Simultaneous Detection of Both Single Nucleotide Variations and Copy Number Alterations by Next-Generation Sequencing in Gorlin Syndrome
por: Morita, Kei-ichi, et al.
Publicado: (2015)

Significant impact of miRNA–target gene networks on genetics of human complex traits
por: Okada, Yukinori, et al.
Publicado: (2016)

Zebrafish brd2a and brd2b are paralogous members of the bromodomain-ET (BET) family of transcriptional coregulators that show structural and expression divergence
por: DiBenedetto, Angela J, et al.
Publicado: (2008)

Inducible In Vivo Silencing of Brd4 Identifies Potential Toxicities of Sustained BET Protein Inhibition
por: Bolden, Jessica E., et al.
Publicado: (2014)

The BET Family Member BRD4 Interacts with OCT4 and Regulates Pluripotency Gene Expression
por: Wu, Tao, et al.
Publicado: (2015)

mTOR inhibition overcomes RSK3-mediated resistance to BET inhibitors in small cell lung cancer
por: Kumari, Anju, et al.
Publicado: (2023)

Comprehensive investigation of CASK mutations and other genetic etiologies in 41 patients with intellectual disability and microcephaly with pontine and cerebellar hypoplasia (MICPCH)
por: Hayashi, Shin, et al.
Publicado: (2017)

Identification of a Biallelic Missense Variant in Gasdermin D (c.823G > C, p.Asp275His) in a Patient of Atypical Gorham‐Stout Disease in a Consanguineous Family
por: Uehara, Daniela Tiaki, et al.
Publicado: (2023)

Upper limb muscle overgrowth with hypoplasia of the index finger: a new over-growth syndrome caused by the somatic PIK3CA mutation c.3140A>G
por: Al-Qattan, Mohammad M., et al.
Publicado: (2018)

The BTK/PI3K/BRD4 axis inhibitor SRX3262 overcomes Ibrutinib resistance in mantle cell lymphoma
por: Pal, Dhananjaya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bhgo5v9nsnkr46bfvgvp7cppgm